Key points are not available for this paper at this time.
Myasthenia gravis is an autoimmune disease associated with several autoantibodies that attack the neuromuscular junction. Some cases are associated with thymoma. The hallmark of management is individualized immunosuppressive therapy.
Nils Erik Gilhus (Wed,) studied this question.